Some name brands can have up to 20 generic equivalents, and I guess that is good news for consumers, and a big part of the reason is due to the major retailers offering the $4 and $9 deals for prescriptions. Overall though, generic sales were down a billion, which might reflect on individuals perhaps...
This is the second approval this week for a generic version of Wellbutrin, earlier this week Watson Pharmaceuticals announced it’s new version. BD The Food and Drug Administration approved a generic copy of an antidepressant made by Impax Laboratories Inc. Regulators gave the drug — a copy of GlaxoSmithKline...
The entire focus is to see whether or not patent laws have been violated and if less expensive generics were in any way stalled from getting to the market place. It all boils down to intellectual-property rights and patient disputes. Interesting that Teva is settling lawsuits and will be...
I wonder if all the name brand companies will one day have nothing but generics? (grin). There’s always this interesting topic too, biosimilars. “Because biosimilars aren't exact duplicates of the original drugs, they don't violate the original drug's patent , enabling legal distribution...
Medical Quack on Reuters. Now this is a sad state of affairs to be the prudent consumer, and yet you are potentially taking money out of your doctor's pocket by doing so when it comes to pay for performance for them, so what's up with this when purchasing $4.00 Generic Drugs. BD...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
09-18-2008
Filed under:
Filed under: Medically Related, Insurance, Pharma/FDA News, My Commentaries, health insurance, Physicians, Pharma, HMO, Generic Drugs, Pay for Performance, Patients
The story keeps getting stranger by the day. A little recent history can be found here. The US is only 2-3% of their entire market so most pharmacies have already found other supplies, such as Walgreens did a few months ago when things started brewing. Will this soon be a Japanese...
Congress and the Department of Justice now join the inquiry about the FDA actions investigating the alleged falsification of test records. This is where joint committees could also stand to shed some light here as both Australia and the UK are working with the FDA in reference to drug factories...
No time wasted here, patent expired yesterday, orders shipping today. Also J and J will release their own generic as well, (can’t beat them – join them) so 2 generic versions ready to go. Teva has an exclusive for a few months before others can join in to manufacture and sell. BD ...
"Pay for Delay Settlements" continue... good news for big pharma, but not so good news for consumers...there is proposed legislation to ban such agreements...interesting fact stated here as well... this year the FDA has been to the hill no less than 10 appearances ...in 2006 they only appeared...